Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02812225 · ClinicalTrials.gov registry record

Non-blinded Data Collection Study of Concussion Using the BrainPulse(TM)

A clinical trial of Mild Traumatic Brain Injury and Brain Concussion, sponsored by Jan Medical.

Completed
Registry status
406
Enrollment target
3
Study locations

NCT02812225 is a study of Mild Traumatic Brain Injury and Brain Concussion that has completed, run by Jan Medical. The registered enrollment target is 406 participants, above the 211-participant average among 43 other Mild Traumatic Brain Injury trials with a reported enrollment target (92% higher). The trial reports 3 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02812225, a study of Mild Traumatic Brain Injury and Brain Concussion, has completed, sponsored by Jan Medical.

COMPLETED
Registry status
406 participants
Enrollment target
3
Study locations

Study Summary

The multi-center study evaluates BrainPulse recordings from subjects with a suspected or confirmed concussion to improve a concussion detection algorithm. Subjects may also consent for a 5 additional follow-ups over a 21-day period to compare the progression of change in their BrainPulse recordings.

Interventions

  • DEVICE BrainPulse

Study Locations (3)

Massachusetts

  • Beth Israel Deconess Medical Center Emergency Medicine - Boston

Ohio

  • University of Cincinnati, Department of Emergency Medicine - Cincinnati

Tennessee

  • Mountain States Health Alliance - Johnson City

Trial Details

FieldValue
Enrollment Target 406 participants
Start Date 2016-06
Est. Completion 2019-01

Sponsor

Jan Medical

9 total trials

What the Registry Record Tells You About NCT02812225

The ClinicalTrials.gov registry entry for NCT02812225 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 406 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 211-participant average among 43 other Mild Traumatic Brain Injury trials with a reported enrollment target (92% higher). The listed sponsor is Jan Medical, which has 9 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Mild Traumatic Brain Injury appearing as the primary indexed condition, and to 1 intervention - of which BrainPulse is the first listed.

NCT02812225 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Massachusetts, Ohio, Tennessee.

Frequently Asked Questions

What is clinical trial NCT02812225 about?

NCT02812225 is a clinical study titled "Non-blinded Data Collection Study of Concussion Using the BrainPulse(TM)". The multi-center study evaluates BrainPulse recordings from subjects with a suspected or confirmed concussion to improve a concussion detection algorithm. Subjects may also consent for a 5 additional follow-ups over a 21-day period to compare the progression of change in their BrainPulse recordings.

What is the current status of trial NCT02812225?

This trial is currently completed. The enrollment target is 406 participants. The study started on 2016-06. Estimated completion is 2019-01.

What conditions does trial NCT02812225 study?

This clinical trial studies the following conditions: Mild Traumatic Brain Injury, Brain Concussion.

What interventions are being tested in trial NCT02812225?

The interventions under investigation include: BrainPulse (DEVICE).

Who is sponsoring clinical trial NCT02812225?

This trial is sponsored by Jan Medical, which has 9 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02812225 being conducted?

This trial has 3 study locations across Massachusetts, Ohio, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Mild Traumatic Brain Injury

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.